Swiss BioRef
Swiss BioRef is a nationwide IT infrastructure in Switzerland that combines clinical laboratory data from multiple hospitals to create precise, patient-specific reference intervals for blood tests. It uses a shared data framework and offers web tools that allow users to generate customized reference values based on factors like age, sex, and medical conditions.
At a glance
Use when
Generating precise, context-specific reference intervals for laboratory tests using real-world multicentre data; when adjusting for patient and analytical covariates is essential; in research or clinical settings requiring up-to-date, population-relevant norms.
Avoid when
Rapid, real-time clinical decision-making at point-of-care where immediate access to reference values is needed without query setup; when data from non-SPHN-compliant sources must be used without harmonization capacity.
Inputs
Multicentre clinical laboratory data (e.g., blood test results), patient demographics (age, sex), ICD-10 diagnoses, analytical metadata (test type, instrument identifiers), encoded under SPHN-compliant formats.
Outputs
Covariate-adjusted, patient group-specific reference intervals for laboratory tests, generated on-the-fly via web applications.
How it works
Swiss BioRef integrates laboratory data from four major Swiss hospitals (approximately 9 million measurements from 250,000 patients) under the Swiss Personalized Health Network (SPHN) semantic framework. It supports the generation of covariate-adjusted reference intervals for over 40 laboratory variables across clinical chemistry, haematology, coagulation, and point-of-care testing. Two web applications—one centralized, statistically detailed, and one decentralized using distributed computing—enable flexible querying and analysis. The system uses harmonized, interoperable data formats, though data harmonization remains resource-intensive due to heterogeneous source systems.
- HTA domains
- Clinical Effectiveness, Organisational aspects, Patient and Social Aspects
- Assumptions
- Data from different clinical laboratories can be harmonized using common semantic standards (SPHN); patient covariates significantly influence laboratory test reference intervals; decentralized and centralized analysis architectures can coexist to meet diverse user needs.
- Strengths
- First multi-cohort infrastructure in Switzerland for precise reference interval estimation,Built on a robust, interoperable semantic framework (SPHN),Supports detailed, patient-specific reference intervals using real-world clinical data,Offers both centralized and decentralized analysis options for flexibility and data governance,Modular and expandable architecture allows onboarding of national and international partners
- Limitations
- Data harmonization is labor-intensive due to heterogeneous data management systems across sites,Direct data provision is limited by technical and organizational differences between data warehouses,Anticipating diverse user requirements for web interfaces remains challenging
- Also known as
- Swiss BioRef, BioRef
Questions this answers
- › How can reference intervals for laboratory tests be made more precise and patient-specific?
- › What role does multi-centre data integration play in improving laboratory medicine standards?
- › How can covariates like age, sex, and comorbidities be used to adjust reference intervals?
- › What infrastructure is needed to support nationwide, interoperable health data sharing for reference interval estimation?
- › Can distributed computing architectures support secure and scalable access to sensitive laboratory data?
- › How can semantic standards like SPHN improve data fusion across clinical laboratories?
References & sources
Related methods
Similar by meaning
- D2.1 Whitepaper on the platform knowledge base and data standards for in silico drug repurposing
- SMART on FHIR Conformant Infrastructure for Recording Patient Reported Outcomes
- Guidelines for Good Database Selection and Use in Pharmacoepidemiology Research
- SPIFD (Structured Process to Identify Fit-For-Purpose Data)
- Drugst.One
Beta record. Generated from the primary source via AI extraction and independent audit, pending final human review.